Abstract
Introduction
• Deep generative models (DGM) are models capable of generating realistic samples and learning hidden information
• DGM used in drug discovery to generate new molecular entities with desirable biological and chemical properties
• Applications in pharmaceutical manufacturing have not been fully explored
• Potential Benefits of DGM
- Aid process design by generating a feasible chain of unit operations for the production of an API/dosage forms
- Improve process understanding through the utilisation of latent variables that may be correlated to process parameters.
• Thousands of data are required to develop a model
• No database that consolidates this information available in literature to be used in DGM for primary or secondary manufacturing domain
• Deep generative models (DGM) are models capable of generating realistic samples and learning hidden information
• DGM used in drug discovery to generate new molecular entities with desirable biological and chemical properties
• Applications in pharmaceutical manufacturing have not been fully explored
• Potential Benefits of DGM
- Aid process design by generating a feasible chain of unit operations for the production of an API/dosage forms
- Improve process understanding through the utilisation of latent variables that may be correlated to process parameters.
• Thousands of data are required to develop a model
• No database that consolidates this information available in literature to be used in DGM for primary or secondary manufacturing domain
Original language | English |
---|---|
Pages | 27-27 |
Number of pages | 1 |
Publication status | Published - 16 May 2022 |
Event | CMAC Annual Open Day 2022 - Glasgow, United Kingdom Duration: 16 May 2022 → 18 May 2022 |
Conference
Conference | CMAC Annual Open Day 2022 |
---|---|
Country/Territory | United Kingdom |
City | Glasgow |
Period | 16/05/22 → 18/05/22 |
Keywords
- Natural Language Processing (NLP)
- pharmaceutical data
- automatic extraction